Double-face urethroplasty in patients with obliterative bulbar strictures post-transurethral resection of the prostate mid-term outcomes in high-volume referral center.

Incidences of post-transurethral resection of the prostate (post-TURP) strictures are between 2.2% and 9.8%. Stricture commonly occurs within the first 6 months. Our objective was to assess the outcomes of patients with obliterative strictures post-TURP that underwent a double-face urethroplasty.

This is a single-center prospective study of 17 patients with obliterative proximal bulbar stricture post-TURP who underwent double-face graft urethroplasty by two surgeons between January 2014 and January 2020. We defined post-TURP obliterative strictures as those patients who presented with complete or almost complete obstruction of the urethral lumen and who have had a history of acute urine retention. We have excluded patients with bladder neck contracture. Primary outcome was treatment success, defined as the no need for further treatments. Secondary outcome was post-urethroplasty continent rate.

Seventeen patients were included in the study with median age of 66 (interquartile range 40-77) years; median time of follow-up was 24 (interquartile range 12-84) months; median stricture length was 4 (interquartile range 2-6) cm. Of the 17 patients, 15 (88.2%) were successful. All patients were continent after urethroplasty.

With mid-term follow-up, treatment of obliterative proximal bulbar strictures with double-face buccal mucosa graft is a safe and effective procedure. Obliterative proximal bulbar strictures merit double-face urethroplasty with high-rate success and functional outcomes.

Asian journal of urology. 2021 Nov 11 [Epub]

Pankaj M Joshi, Manuel Hevia, Yatam Lakshmi Sreeranga, Marco Bandini, Amey Patil, Shreyas Bhadranavar, Vipin Sharma, Sandeep Bafna, Sanjay B Kulkarni

Kulkarni Reconstructive Urology Center, 3, Rajpath Society, Paud Road, Pune 411038, India., Urology Department, Ramón y Cajal University Hospital, IRYCIS, University of Alcalá, Madrid, Spain., Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita Salute, San Raffaele University, Milan, MI, Italy.